SciELO - Scientific Electronic Library Online

 
vol.10 número2The resistance in HIV positive patientsEvaluation of program implementation through case studies of malaria, dengue, tuberculosis and hanseniasis in Legal Amazon índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Boletim de Pneumologia Sanitária

versión impresa ISSN 0103-460X

Bol. Pneumol. Sanit. v.10 n.2 Rio de Janeiro dic. 2002

 

INFORMES

 

2- RESUMOS DOS TRABALHOS APRESENTADOS NO 33º WORLD
CONFERENCE ON LUNJ HEALTH - MONTREAL/CANADÁ - 2002

 

MDR-TB: resistence to INH Associated with RMP, and only to RMP

 

 

Natal S*; Toledo A; Penna MLF; Valente J

CRPHF/FNS/MS & IMS/UERJ. Rio de Janeiro. Brazil

 

 

Resistance is a major problem within our milieu. Drugs should be handled by people with adequate knowledge of both the pharmacology of the drugs used in the treatment of tuberculosis and its etiopathogeny.

Discontinuance of treatment remains the great "villain" for the poor performance of the TCP.

Patients with a Tb treatment history, even if last discharged for "cure", should be adequately monitored for resistance detection.

Special care should be given to patients with Tb- HIV co-infection.

Tuberculosis is no simple task, as one believed in the early 80s, it is still the disease that kills more adults in productive age, and annually it can kill more than AIDS.

It is important that people involved with "tuberculosis", at all levels, keep in mind that the guidelines are important as a TCP strategy, but that every patient is an individual with his/her own particularities.

 

*E-mail:sonianatal@uol.com.br